AINostix (XAIR): Nilai Akuntansi Perusahaan

Beyond Air, Inc. (XAIR) is developing the LungFit system under the guidance of experienced executives whose sales transparency is proven and whose efficiency is evidenced by a future path to break-even. Production is based on contract electronics assembly and outsourced logistics management. The market trend demonstrates the 0.00 metric, visualizing the business dynamics. Looking ahead, Beyond Air, Inc. (XAIR) relies on direct contracts with hospitals and distributors, excluding mergers.

Book value represents the net asset value of Beyond Air, Inc. after deducting all debt obligations, serving as a fundamental anchor for determining the fair value of the business. By analyzing the current book value of equity, an investor can see the tangible basis of this medical innovator, whose developments in nitric oxide therapy shape the company's real intrinsic value despite the volatility of market quotes.